A Phase I Multicenter Study of E1A Gene Therapy for Patients with Metastatic Breast Cancer and Epithelial Ovarian Cancer That Overexpresses HER-2/neuor Epithelial Ovarian Cancer. M.D. Anderson Cancer Center, Houston, Texas

This publication has 39 references indexed in Scilit:

• Simultaneous Suppression of Progression Marker Genes in the Highly Malignant Human Melanoma Cell Line BLM after Transfection with the Adenovirus-5 E1A Gene
  Biochemical and Biophysical Research Communications, 1996
• E1a induces the expression of epithelial characteristics.
  The Journal of cell biology, 1994
• Disruption of epithelial cell-matrix interactions induces apoptosis
  The Journal of cell biology, 1994
• Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit
  Cell, 1992
• Correlation of c-erbB-2 Protein Expression and Lymph Node Status in Early Gastric Cancer
  Oncology, 1992
• Overexpression of the c‐erbB‐2/neu–encoded p185 protein in primary lung cancer
  Molecular Carcinogenesis, 1992
• A novel cationic liposome reagent for efficient transfection of mammalian cells
  Biochemical and Biophysical Research Communications, 1991
• Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185 ^{erb B2}
  Science, 1990
• Intermolecular association of the p185 protein and EGF receptor modulates EGF receptor function
  Cell, 1990
• Direct sequencing analysis of transmembrane region of human neu gene by polymerase chain reaction
  Molecular Carcinogenesis, 1990